Image: PD
1. Radiotherapy administered after mastectomy and axillary dissection decreased 10-year recurrence and 20-year mortality in women with node-positive breast cancer.
2. No reduction in recurrence and mortality was shown for women with node-negative breast cancer who were given radiotherapy following mastectomy and axillary dissection.
Evidence Rating Level: 1 (Excellent)
Study Rundown: Radiotherapy has been used in clinical practice to treat any remaining tumor foci following mastectomy and axillary dissection in women with node positive breast cancer. Current guidelines recommend adjuvant radiotherapy after mastectomy for women with four or more positive axillary lymph nodes. However, no previous analysis has clearly shown the utility of radiotherapy for women with one to three positive nodes. This meta-analysis suggests a benefit of radiotherapy in this population, as evidenced by decreased rates of recurrence and breast cancer mortality in women with one to three positive lymph nodes. A limitation of this study is how far in the past the women were treated. Patients who received radiotherapy between the years of 1964 to 1980 were included. Advances made in the effectiveness of more non-invasive treatments, particularly, targeted systemic therapies, likely renders patients today at a lower overall risk for recurrence and mortality. As a result, it becomes difficult to generalize these results for today’s population.
Click to read the study in Lancet
In-Depth [meta-analysis]: Over 8000 women from 22 randomized clinical trials of adjuvant radiotherapy versus no radiotherapy following mastectomy with axillary dissection were included in the analysis. For women with no positive nodes after axillary dissection, there was no change in rates of local recurrence, overall recurrence, or breast cancer mortality. Radiotherapy did reduce the local recurrence (p<.00001), overall recurrence (RR = 0.68, 95% CI 0.57-0.82, p<.0001) and breast cancer mortality (RR = 0.80, 95% CI 0.67-0.95, p=.01) in women with one to three positive nodes. 86% of these women were concurrently on systemic therapy, and significant reductions in all three parameters were maintained with radiotherapy. Reductions in local recurrence (p<.00001), overall recurrence (RR = 0.79, 95% CI 0.69-0.90, p<.001), and breast cancer mortality (RR = 0.87, 95% CI 0.77-0.99, p<.05) were also found in women shown to have four or more positive lymph nodes.
©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.
